|
MRPL53 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.029600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.806050E-02 |
| Normal-vs-Stage2 |
6.294000E-01 |
| Normal-vs-Stage3 |
8.828000E-01 |
| Normal-vs-Stage4 |
4.887400E-01 |
| Stage1-vs-Stage2 |
3.165200E-01 |
| Stage1-vs-Stage3 |
8.611800E-02 |
| Stage1-vs-Stage4 |
7.966100E-02 |
| Stage2-vs-Stage3 |
6.968600E-01 |
| Stage2-vs-Stage4 |
4.125800E-01 |
| Stage3-vs-Stage4 |
4.576800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.379800E-03 |
| Normal-vs-AfricanAmerican |
9.529400E-01 |
| Normal-vs-Asian |
5.560000E-01 |
| Caucasian-vs-AfricanAmerican |
3.597400E-03 |
| Caucasian-vs-Asian |
1.423410E-01 |
| AfricanAmerican-vs-Asian |
6.791800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.362230E-01 |
| Normal-vs-Female |
5.747900E-02 |
| Male-vs-Female |
5.435000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.451600E-02 |
| Normal-vs-Extreme_Weight |
1.491560E-02 |
| Normal-vs-Obese |
3.680000E-01 |
| Normal-vs-Extreme_Obese |
3.266100E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.724000E-01 |
| Normal_Weight-vs-Obese |
2.527000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.886000E-01 |
| Extreme_Weight-vs-Obese |
7.151900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.564400E-01 |
| Obese-vs-Extreme_Obese |
2.437000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.586200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.271200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.519660E-02 |
| Normal-vs-Age(81-100Yrs) |
8.430800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.587000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.567800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.839600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.800760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.248200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.254980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.599300E-03 |
| Normal-VS-Type2 PRCC |
7.513000E-01 |
| Normal-VS-KIRP CIMP |
4.895900E-02 |
| Normal-VS-Unclassified PRCC |
2.866200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.663000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.61846999999771E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.480180E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.620000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.420400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.315390E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.208000E-01 |
| Normal-vs-N1 |
4.744200E-01 |
| Normal-vs-N2 |
3.716200E-01 |
| N0-vs-N1 |
7.847700E-02 |
| N0-vs-N2 |
2.319400E-01 |
| N1-vs-N2 |
3.083400E-01 |
|
|
